Miranda Liu

Perineal tearing affects up to 90% of women birthing vaginally. It is painful and costly, estimated at over $10 billion annually in the US alone and for too long it has been accepted as an inevitable part of childbirth. We dont accept that. Peripear is developing a wearable medical device that translates an evidence-based midwifery intervention, warm compress application during the second stage of labour, into a consistent, hands-free clinical tool which is designed to reduce perineal tearing at the moment it most commonly occurs. We are backed by InnovateUK, 85% through our pre-seed round and in active conversation with US health systems about pilot partnerships. Our functional prototype is complete and was built in under two months. Behind Peripear are two founders with complementary depth. Nina brings 14 years of NHS and private midwifery practice with direct experience of the clinical gap this device is designed to address. Eviatar brings over a decade of healthtech leadership, having raised more than $75M and scaled MedTech companies from concept to market as CXO, supported by a PhD from the University of Cambridge and a visiting scholarship at MIT. We are building toward US hospital pilots, clinical evidence generation and long-term integration into standard perinatal care. If you are an investor, clinical innovator or health system leader who believes maternity care deserves better tools, wed always welcome a conversation.

Perineal tearing affects up to 90% of women birthing vaginally. It is painful and costly, estimated at over $10 billion annually in the US alone and for too long it has been accepted as an inevitable part of childbirth. We dont accept that. Peripear is developing a wearable medical device that translates an evidence-based midwifery intervention, warm compress application during the second stage of labour, into a consistent, hands-free clinical tool which is designed to reduce perineal tearing at the moment it most commonly occurs. We are backed by InnovateUK, 85% through our pre-seed round and in active conversation with US health systems about pilot partnerships. Our functional prototype is complete and was built in under two months. Behind Peripear are two founders with complementary depth. Nina brings 14 years of NHS and private midwifery practice with direct experience of the clinical gap this device is designed to address. Eviatar brings over a decade of healthtech leadership, having raised more than $75M and scaled MedTech companies from concept to market as CXO, supported by a PhD from the University of Cambridge and a visiting scholarship at MIT. We are building toward US hospital pilots, clinical evidence generation and long-term integration into standard perinatal care. If you are an investor, clinical innovator or health system leader who believes maternity care deserves better tools, wed always welcome a conversation.

Aries Innovation is a venture and partnership platform dedicated to accelerating the adoption of transformative innovations across industries. We believe that meaningful progress happens when visionary ideas meet strategic capital and the right partners. At Aries Innovation, we bridge the gap between startups, corporates, and investors — driving collaboration through investment, partnership, and joint venture models. Our mission is to turn bold ideas into scalable, impactful solutions that shape a more sustainable and connected future. Guided by the pioneering spirit of Aries, we lead with courage, agility, and purpose — empowering innovators to move faster, smarter, and further together. What We Do: Invest: Support innovative ventures through strategic and financial capital. Partner: Build alliances between startups and corporates to accelerate technology adoption. Co-Create: Launch joint ventures that unlock new market opportunities and shared value.

Antler is one of the most active early-stage investors globally. The firm leads in ‘Day Zero’ investing, an approach to venture capital focused on partnering with founders pre-launch. Antler systematically removes capital and network constraints for early-stage technology entrepreneurs by providing co-founder matching, deep business model validation, initial capital, expansion support, and follow-on funding. The firm is present in 27 cities across most leading technology ecosystems globally and has made over 1,300 investments into early-stage startups. Antler has been repeatedly recognized by Pitchbook as the world’s most active angel and seed-stage investor.

Nippon Express services continue to expand the globe, achieving a five-point framework across Japan, the Americas and Europe, and stretching into the rapidly developing markets of East Asia, South Asia and Oceania. We see our role as a logistics consultant, providing one-stop business solutions that connect people and companies beyond national and regional boundaries, through diverse logistics modes, integrating land, air, and marine transport. We have also optimized our services on a global level to handle the mounting spread of inventory worldwide. Nippon Express offers a smooth one-stop service, from Procurement Logistics, optimizing the logistics required in product manufacturing processes, to Distribution Logistics, streamlining the product transport flow to ensure safe delivery to the end user. Nippon Express offers incomparable “strategic logistics,” combining distinctive information systems, logistics infrastructure and transport modes. This was achieved only by discarding conventional transport methods restricted by national and industrial boundaries and creating a path toward a logistics environment that optimizes each companys assets.